key: cord-0735925-9ax6ej4h
authors: Musa, Sherief; Abdel Alem, Shereen; Amer, Khaled; Elnagdy, Tarek; Hassan, Wael A.; Ali, Mohamed A.; Gaber, Yasmine; Badary, Hedy A.; Tantawi, Omnia; Abdelmoniem, Reham; Radwan, Amr; Yousof, Hanaa; Shawky, Shereen; Talaat, Hala; Fouad, Rabab; Kassem, Abdel Meguid
title: Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: a prospective cohort study
date: 2021-06-10
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2021.06.001
sha: 40c66387c13d59f085718106d5d8709daea83d7e
doc_id: 735925
cord_uid: 9ax6ej4h

BACKGROUND: Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). METHODS: We analyzed a cohort of 386 HCWs in a university hospital in Egypt and 725 volunteers not affiliated to any healthcare facility (non-healthcare workers - NHCWs). Participants provided a nasopharyngeal swab and serum samples for SARS-CoV-2 nucleic acid and SARS-CoV-2-specific antibodies, respectively. HCWs who tested positive by either test were sequentially monitored. RESULTS: At baseline, point prevalence of viral carriage was 11.4% in HCWs (n = 44/386) and 11.9% in NHCWs (86/725). The cumulative prevalence of SARS-CoV-2 infection among HCWs considering all studies was 25.6%, which was statistically lower than in NHCWs (41.0%). Prevalence was greatest among janitorial staff (45.9%) and the most affected departments were gastroenterology (31.1%), and emergency medicine (30.0%). Prior anosmia, fever or headache were associated with higher odds of positivity for SARS-CoV-2 infection. Regarding serial antibody measurements, RT-PCR-positive HCWs displayed IgG detection rates of 29.5%, 70% and 60% at visit 1, visit 2 and visit 3, respectively with slow decline of median IgG antibody titers, whereas, corresponding detection rates for total Ig antibodies were 50%, 90.3%, and 88.9%, respectively with increasing median titers. NAbs measured at each time point were positively correlated with total Ig levels, whereas IgG levels were positively correlated with NAbs at visit 1 and visit 3. CONCLUSION: Our results demonstrate lower cumulative prevalence of SARS-CoV-2 infection in HCWs than general population and suggest that asymptomatic HCWs exhibit considerable IgG and total Ig antibodies response as well as NAbs for up to 120 days, with positive correlation in between.

The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China in late 2019 [1] . A wide spectrum of coronavirus disease 2019 (COVID- 19) has been depicted, ranging from severe cases requiring hospitalization to asymptomatic individuals, who are silent spreaders [2] . Healthcare workers (HCWs) are presumably exposed to a higher risk of acquiring the disease, with previous studies showing infection rates of up to 14% in symptomatic and 7.1% in asymptomatic HCWs [3, 4] . A recent meta-analysis found that the proportion of SARS-CoV-2 positive HCWs among all patients with COVID-19 was 10.1%, with variable proportions between countries: China, 4.2%; Italy, 9%; and USA, 17.8% [5] . In Egypt, the first confirmed case was announced on February 14th, 2020 [6] , with 2.4% of reported cases in April 2020 being HCWs [7] (Fig. 1) .

J o u r n a l P r e -p r o o f Seroprevalence studies and understanding risk factors for SARS CoV-2 infection among HCWs are necessary to assess exposure, safeguard the workforce and maintain healthcare services, particularly in resource-limited health systems [8] .

Patients infected with SARS-CoV-2 develop antibodies against virus-specific proteins and antibodies targeting the receptor-binding domains of the spike protein can neutralize the virus [9] .

Despite growing knowledge on immunity against SARS-CoV-2, the correlation between quality, quantity and longevity of immune responses and protection against reinfection, remains to be elucidated, so that effective immune-based treatments and vaccines can be developed. [10] .

In this study, we evaluated baseline prevalence of SARS-CoV-2 infection via reverse transcription polymerase chain reaction (RT-PCR) and determination of anti-SARS-CoV-2 antibodies within a cohort of previously undiagnosed HCWs and non-HCWs recruited into a study 

This study was conducted at Kasr Al-Aini University Hospital, Cairo University, a 5600-beds referral hospital complex providing health services in all specialties, with COVID-19 cases served in a dedicated hospital. Eligible HCWs were defined as those who deliver healthcare services to patients in Kasr Al-Aini University Hospital at the time of the study, either directly as physicians or nurses, or indirectly as administrative officers, transporters, or cleaners. Non-healthcare workers (NHCWs) were recruited randomly as volunteers not affiliated to any healthcare facility.

Individuals previously tested positive for SARS-CoV-2 via RT-PCR or those self-isolating at home due to symptoms typical of COVID-19 during the last 14 days were excluded from the study.

Ethical committee approval was obtained for the study. After informed consent, participants completed a questionnaire comprising demographics, work location, occupation, medical history, exposure to suspected or confirmed COVID-19 cases, in addition to self-reported prior symptoms compatible with COVID-19.

Nasopharyngeal swabs (NPS) were collected at designated sites and transferred with Universal Transport Media (UTM). SARS-CoV-2 RNA was extracted using QIAGEN extraction kit. The extracted RNA was reverse transcribed into cDNA and amplified in one step using TaqPath™ COVID-19 CE-IVD RT-PCR ComboKit from Thermofisher Scientific, Revision D.0 (Cat.# A48067). Fast Dx Applied Biosystems 7500 real-time thermal cycler was used for amplification.

Probes were annealed to three target sequences specific to SARS-CoV-2: ORF1ab, nucleocapsid J o u r n a l P r e -p r o o f (N) and spike (S) primers/probes for bacteriophage MS2. Two of the three genes and the MS2 (internal process control) must be positive or the result was considered inconclusive.

Detection of SARS-CoV-2 IgM was done using the lateral flow immunochromatographic assay, COVID-19 IgM/IgG antibody rapid diagnostic test (Artron Laboratories, Burnaby, Canada). The assay has a sensitivity of 93.4% and specificity of 97.7%, as reported by the manufacturer. 10 μL serum was added and incubated for 20-30 seconds. Subsequently, 2 drops of buffer were added, and the results were detected visually after 15 minutes. The presence of both the control line and IgM line indicated a positive result for IgM antibody.

Plasma samples were prepared from whole blood following centrifugation for 20 minutes at 2000 g at room temperature. All plasma samples were heat-inactivated for 30 minutes at 56°C and stored at −80°C. IgG antibodies and total Ig antibodies against SARS-CoV-2 were detected using VITROS anti-SARS-CoV-2 IgG test and VITROS anti-SARS-CoV-2 total test, respectively (Ortho Clinical Diagnostics, USA). Both tests are chemiluminescent immunoassays for qualitative detection of either serum IgG or total Ig antibodies (including IgG, IgM and IgA) against spike (S) glycoprotein, with a sensitivity and specificity of 90% and 100% respectively, as reported by the manufacturer. In the first stage antibodies to SARS-CoV-2 present in the sample bind with SARS-CoV-2 spike protein S1 antigen coated on wells. In the second stage horseradish peroxidase (HRP)-labeled murine monoclonal anti-human antibodies are added in the conjugate reagent. The conjugate binds specifically to the antibody portion of the antigen-antibody complex. The bound HRP conjugate is measured by a luminescent reaction, indicating the amount of SARS-CoV-2 antibody present. A cut-off value ≥1 was considered reactive for both antibodies. Serum samples were heat-inactivated for 30 minutes at 56°C. Two-fold serial dilutions, starting from 1:10 were then mixed with an equal volume of viral solution containing 100 TCID50 of SARS-CoV-2. The serum-virus mixture was incubated for 1 hour at 37°C in a humidified atmosphere with 5% CO2. After incubation, 35 μl of the mixture at each dilution was added in duplicate to a cell plate containing a semi-confluent vero E6 cell monolayer and incubated for 2 hours at the same condition. The inoculum was aspirated and 150 ul medium was added to each well. The plates were incubated for 5 days at 37 o C in a CO2-incubator, before the cultures were inspected under a light microscope for the presence of a cytopathic effect (CPE). Neutralizing antibody titers were expressed as the reciprocal of the last dilution of serum that completely inhibited virus-induced CPE.

Finally, HCWs who tested positive for SARS-CoV-2 infection by either nucleic acid detection test or serological tests were sequentially monitored: 2 months later (visit 2) and another 2 months afterwards (visit 3).

Statistical analyses and graphical presentations were performed using GraphPad Prism software version 9.0 (San Diego, USA). Within HCWs, frequencies of positive test results were compared in relation to demographic and clinical characteristics using chi-squared tests. Univariate analysis and multiple logistic regression were performed using positivity as the outcome variable. The comparison between groups was done using Wilcoxon signed-rank test, Mann-Whitney U test, and Krusal-wallis test to assess changes in antibody titers at baseline and follow-up periods as appropriate. Correlations between obtained different antibody titers were estimated by Spearman rank correlation coefficients. For all analyses, a significance level of 5% was established. [11] . Therefore, HCWs with positive antibodies and negative RT-PCR were re-tested a week after the initial NPS, all of whom were persistently negative by RT-PCR.

A comparison of characteristics of HCWs based on SARS-CoV-2 status is presented in table 1.

J o u r n a l P r e -p r o o f with a cumulative prevalence 19.9% [14] .

Data from many studies support the hypothesis of higher SARS-CoV-2 infection rates in

HCWs compared with the general population, suggesting an occupational risk of exposure to SARS-CoV-2 [15, 16] . However, this was not the case in our study, where SARS-CoV-2-positivity rates by RT-PCR were found to be similar in HCWs and NHCWs (~11%) and this was more obvious in seroprevalence data where SARS-CoV-2 seropositivity was significantly higher in non-HCWs in whom the cumulative prevalence of infection was 41%. Given that HCWs are presumably more exposed to the virus, parallel or reversed trends in infection rates in HCWs and the general public may signify community transmission as a greater source of infection especially in presence of peculiar cultural factors in our community. Another contributing factor is that adequate supply of personal protective equipment (PPE), which was the case in our university hospital, is protective and should ease HCWs' concerns.

HCWs, have shown conflicting results. Some studies have reported high rates of positivity among clinicians [17] , nurses [12] or support roles [15] , whereas other studies demonstrated no variation in infection rates by job role [18, 19] . In our study, we observed higher frequency in janitorial staff and administrative employees, and lower frequency among physicians followed by nurses, who despite more patient-near contact, have greater awareness and training leading to proper PPE use.

In order to study the differential influence of work-related exposure within hospital environment, HCWs were classified according to their medical department. Cumulative prevalence of SARS-CoV-2 among HCWs assigned to gastrointestinal and emergency departments was higher (31.1% and 30.0%, respectively) compared to other departments. This seems logical due to more frequent and urgent encounters with patients of unknown SARS-CoV-2 status and generation of infected aerosols during endoscopic procedures [20] .

Identifying symptoms associated with SARS-CoV-2 infection, may guide HCWs screening and self-isolation [21] . In our cohort, 10% of HCWs with positive tests for SARS-CoV-2 did not recall any symptoms consistent with COVID-19 in the preceding months. Despite being lower

than several studies where 20-50% of infections remain subclinical, this finding supports the inadequacy of relying on symptoms for screening HCWs [22] . Participants were asked to document symptoms over the prior 3-4 months, and although most COVID-19 symptoms are common to many other upper respiratory viral infections, the presence of prior anosmia, fever, or headache were associated with higher odds of positivity. This finding is consistent with several studies that found anosmia to have higher odds of PCR positivity [23] . Although myalgia, fatigue, sore throat and cough have been reported to be associated with SARS-CoV-2 positivity, we did not find significant associations despite their high prevalence in our study population [24] .

In the face of SARS-CoV-2 vaccines and viral mutations, it is important to understand the dynamics of immune responses following natural infection. Previous reports observed higher antibody levels earlier in patients with severe/critical infections compared to those with mild/moderate disease [25, 26] , but less is known about the magnitude and durability of antibody response in asymptomatic SARS-CoV-2 infected individuals [27] . As in other viral infections,

CoV-2 frequently test for IgM antibody isotype to cover early immune responses as well as IgG antibody isotype indicating recovery period or prior infection [28] , whereas IgA antibody has been analyzed in few studies [29] .

Our results showed that positive rates of SARS-CoV-2 specific IgG /total Ig antibodies in PCRpositive HCWs were higher and maintained over time than in PCR-negative HCWs. Therefore, we hypothesized that those HCWs with negative RT-PCR results had been previously infected by SARS-CoV-2 few weeks prior to study recruitment, when the local spread of SARS-CoV-2 in Egypt was on the rise and the timing of sample collection was later in disease course.

IgG levels declined slowly but remained relatively stable up to 120 days mainly in PCR-positive

HCWs. On the other hand, we noted that total Ig levels remained stable and continued to increase up to 120 days regardless PCR results. The immunoglobulin isotype that was elevated to sustain and increase total Ig levels need to be further investigated.

NAbs are considered a key player following natural infection or vaccines [9] . Importantly, we found evidence that asymptomatic individuals with SARS-CoV-2 were capable of generating NAbs at heterogenous titers. The neutralizing activity was maintained at neutralization titers 1:40 up to 120 days in PCR-positive HCWs, in which 80% of them had detectable activity, while those measured in PCR-negative HCWs were maintained up to 60 days and then started to decline at neutralization titers 1:20. This observation has been consistently reported in similar studies as well [30, 31] .

Another encouraging finding from our study is that neutralization activity was positively correlated to IgG/total Ig antibodies. This might be explained that anti-SARS-CoV-2 IgG/total Ig antibody of our assay could detect neutralizing antibodies directed against the spike (S) protein since IgG/total Ig antibodies target the S1 subunit of the S protein of SARS-CoV-2 which is necessary for viral attachment and entry into host cells [32] . This suggests that levels of IgG/total

Ig measured with CLIA can give a clue on the presence of NAbs directed against SARS-CoV-2, J o u r n a l P r e -p r o o f particularly in vaccinated individuals, without the cost, hazards, time, and expertise needed for neutralizing assays. In the same context, competitive neutralization assays have been designed to replace live-virus-based neutralization test [33] .

In conclusion, the cumulative prevalence of SARS-CoV-2 among HCWs was lower than in general population. Our data suggest that asymptomatic PCR- 

After multivariable analysis

and were categorized based on baseline RT-PCR results. Notably, the proportion of PCR-positive HCWs who had positive results with three antibodies (IgG, total Ig, and NAbs) increased in each visit from 27.3% (12/44) to 41.9% (13/31) and 50% (5/10) at visit 1, visit 2, and visit 3, respectively indicating that antibodies' detection rate increased with time since RT-PCR positivity. In contrast, the proportion of PCR-negative HCWs who had positive results with these antibodies in each visit decreased from 49

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients

COVID-19: PCR screening of asymptomatic health-care workers at London hospital

First experience of COVID-19 screening of health-care workers in England

COVID-19 in health care workers -A systematic review and meta-analysis

Global burden of COVID-19 pandemic on healthcare workers

Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel

Value of Diagnostic Testing for SARS-CoV-2/COVID-19. mBio

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of and association with severity

COVID-19 Testing: The Threat of False-Negative Results

COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of

Clinical Characteristics, and Outcomes

Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis

Impact of SARS CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. Elife

Analysis of the Infection Status of Healthcare Workers in Wuhan During the COVID-19 Outbreak: A Cross-sectional Study

Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan

Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center

Risk of COVID-19 Transmission During Gastrointestinal Endoscopy

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish

Smell and taste symptombased predictive model for COVID-19 diagnosis

Real-time tracking of self-reported symptoms to predict potential COVID-19

Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Coronavirus infections and immune responses

SARS-CoV-2 infection serology validation of different methods: usefulness of IgA in the early phase of infection

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

SARS-CoV-2 Serum neutralization assay: A traditional tool for a brand-new virus